Bal Pharma Ltd. - Research Center
524824 BALPHARMA Group (B) BSE data
Add to watchlist
| Results | |
| Statement |
P&L
|
| More |
Profit loss account
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Income | |||||
| Operating income | 303.10 | 280.37 | 249.31 | 170.67 | 223.08 |
| Expenses | |||||
| Material consumed | 170.39 | 166.77 | 150.83 | 84.54 | 117.23 |
| Manufacturing expenses | 6.71 | 5.37 | 4.70 | 1.14 | 2.74 |
| Personnel expenses | 51.91 | 44.46 | 39.62 | 48.77 | 48.45 |
| Selling expenses | 2.90 | 2.22 | 1.41 | 3.19 | 2.62 |
| Adminstrative expenses | 45.16 | 38.35 | 26.43 | 26.28 | 31.73 |
| Expenses capitalised | - | - | - | - | - |
| Cost of sales | 277.07 | 257.16 | 222.99 | 163.92 | 202.77 |
| Operating profit | 26.03 | 23.20 | 26.32 | 6.75 | 20.31 |
| Other recurring income | 2.15 | 6.49 | 2.69 | 3.62 | 2.75 |
| Adjusted PBDIT | 28.19 | 29.69 | 29.01 | 10.37 | 23.05 |
| Financial expenses | 12.16 | 10.40 | 11.96 | 12.42 | 12.53 |
| Depreciation | 7.48 | 7.24 | 7.26 | 7.03 | 6.12 |
| Other write offs | - | - | - | - | - |
| Adjusted PBT | 8.55 | 12.06 | 9.80 | -9.08 | 4.41 |
| Tax charges | 2.42 | 3.48 | 0.70 | -0.17 | -2.35 |
| Adjusted PAT | 6.13 | 8.58 | 9.10 | -8.90 | 6.76 |
| Non recurring items | - | - | - | - | - |
| Other non cash adjustments | - | - | - | - | - |
| Reported net profit | 6.13 | 8.58 | 9.10 | -8.90 | 6.76 |
| Earnigs before appropriation | 48.49 | 43.85 | 35.27 | 27.88 | 38.49 |
| Equity dividend | 1.56 | 1.48 | - | 1.13 | 1.71 |
| Preference dividend | - | - | - | - | - |
| Dividend tax | - | - | - | 0.29 | - |
| Retained earnings | 46.94 | 42.37 | 35.27 | 26.47 | 36.79 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis